Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 3, 2013, Pages 597-602

  O'Brien, Lesley D ^a   Wills, Kiri L ^a   Segsworth, Blair ^a   Dashney, Brittany ^a   Rock, Erin M ^a   Limebeer, Cheryl L ^a   Parker, Linda A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Anxiety; Appetite; Cannabidiol; Cannabigerol; Cannabinoid; CB1; Delta 9 tetrahydrocannabinol; Depression; Palatability; Rimonabant; Tetrahydrocannabivarin

Indexed keywords

ANXIOLYTIC AGENT; CANNABIDIOL; CANNABIGEROL; CANNABINOID; CANNABIS; RIMONABANT; SACCHARIN; TETRAHYDROCANNABINOL; TETRAHYDROCANNABIVARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CHEMICAL REACTION; DRUG EFFECT; LONG TERM EXPOSURE; MALE; NONHUMAN; PALATABILITY; PRIORITY JOURNAL; RAT; TASTE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CANNABIDIOL; CANNABINOID RECEPTOR ANTAGONISTS; CANNABINOIDS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG INVERSE AGONISM; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SACCHARIN; TASTE; TASTE PERCEPTION; TETRAHYDROCANNABINOL;

ANIMALIA; CANNABIS;

EID: 84869121560     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.10.008     Document Type: Article

References (58)

1. C. Arevalo, R. de Miguel, and R. Hernandez-Tristan Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters Pharmacol Biochem Behav 70 2001 123 131 (Pubitemid 32786974)
2. M. Arnone, J. Maruani, F. Chaperon, M. Thiebot, M. Poncelet, and P. Soubrie Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors Psychopharmacology 132 1997 104 106 (Pubitemid 27303746)
3. C.E. Beyer, J.M. Dwyer, M.J. Piesla, B.J. Platt, R. Shen, and Z. Rahman Depression-like phenotype following chronic CB1 receptor antagonism Neurobiol Dis 39 2010 148 155
4. P. Blier, and C. de Montigny Current advances and trends in the treatment of depression Trends Pharmacol Sci 15 1994 220 226 (Pubitemid 24210726)
5. D. Bolognin, B. Costa, S. Maione, F. Comelli, and P. Marini The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice Br J Pharmacol 160 2010 677 687
6. M. Bourin, and M. Hascoët The mouse light/dark box test Eur J Pharmacol 463 2003 55 65 (Pubitemid 36205072)
7. 1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats Psychopharmacology 199 2008 223 230
8. 1A receptor antagonist Br J Pharmacol 159 2010 129 141
9. R. Christensen, P.K. Kristensen, E.M. Bartels, H. Bliddal, and A. Astrup Efficacy and safety of the weight-loss drug Rimonabant: A meta-analysis of randomised trials Lancet 370 2007 1706 1713 (Pubitemid 350100788)
10. N. Cluny, V. Vemuri, A. Chambers, C.L. Limebeer, H. Bedard, J. Wood, B. Lutz, A. Zimmer, L.A. Parker, A. Makriyannis, and K. Sharkey A novel, peripherally restricted, cannabinoid 1 (CB1) receptor antagonist AM6545 reduces food intake and body weight, but does not cause malaise, in rodents Br J Pharmacol 161 2010 629 642
11. B. Costall, B.J. Jones, M.E. Kelly, B.J. Naylor, and D.M. Tomkins Exploration of mice in a black and white test box: validation as a model of anxiety Pharmacol Biochem Behav 32 1989 777 785 (Pubitemid 19162403)
12. J. De Vry 5-HT1A receptor agonists: recent developments and controversial issues Psychopharmacology 121 1995 1 26
13. M. ElBatsh, N. Assareh, C.A. Marsden, and D.A. Kendall Anxiogenic-like effects of chronic cannabidiol administration in rats Psychopharmacology 221 2012 239 247
14. S.E. File Models of anxiety Br J Clin Pract 38 1985 15 20 (Pubitemid 16049810)
15. C. Garcia, C. Palomo-Garo, M. Garcia-Arencibia, J. Ramos, R. Pertwee, and J. Fernandez-Ruiz Symptom-relieving and neuroprotective effects of the phytocannabinoid Delta-THCV in animal models of Parkinson's disease Br J Pharmacol 163 2011 1495 1506
16. G. Griebel, J. Stemmelin, and B. Scatton Effects of the cannabinoid CB1 receptor antagonist Rimonabant in models of emotional reactivity in rodents Biol Psychiatry 57 2005 261 267 (Pubitemid 40187370)
17. H.J. Grill, and R. Norgren The taste reactivity test I mimetic responses to gustatory stimuli in neurologically normal rats Brain Res 143 1978 263 279 (Pubitemid 8277909)
18. F.V. Gomes, L.B. Ressel, and F.S. Guimaraes The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors Psychopharmacology 213 2011 465 473
19. J. Haller, N. Bakos, M. Szirmay, C. Ledent, and T.F. Freund The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety Eur J Neurosci 16 2002 1395 1398 (Pubitemid 35340861)
20. J. Haller, B. Varga, C. Ledent, and T.F. Freund CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1 specific agents Behav Pharmacol 15 2004 299 304 (Pubitemid 39062560)
21. S. Higgs, C. Williams, and T.C. Kirkham Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta-9-tetrahydrocannabinol, 2-arachidonoyl glycerol and SR141716 Psychopharmacology 165 2003 370 377 (Pubitemid 36223078)
22. A.J. Hill, S.E. Weston, N.A. Jones, I. Smith, S.A. Bevan, and E.M. Williamson Delta-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats Epilepsia 51 2010 1522 1532
23. C.J. Hillard Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol Prostaglandins Other Lipid Mediat 61 2000 3 18 (Pubitemid 30216485)
24. A. Holmes Targeted gene mutation approaches to the study of anxiety-like behavior in mice Neurosci Biobehav Rev 25 2001 261 273 (Pubitemid 32506877)
25. D.R. Janero, and A.A. Makriyannis Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis Expert Opin Emerg Drugs 14 2009 43 65
26. 9-Tetrahyrdrocannabinol on sucrose palatability as measured by the taste reactivity test Physiol Behav 86 2005 475 479 (Pubitemid 41586243)
27. M. Jarrett, J. Scantlebury, and L.A. Parker Effect of Δ9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test Physiol Behav 90 2007 425 430 (Pubitemid 46177106)
28. C.S. Kearn, M.J. Greenberg, R. DiCamelli, K. Kurzawa, and C.J. Hillard Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange J Neurochem 72 1999 2379 2387 (Pubitemid 29242188)
29. 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture Neuropharmacology 46 2004 709 715 (Pubitemid 38292975)
30. J.E. Koch Delta-9-THC stimulates food intake in Lewis rats effects on chow, high fat and sweet high fat diets Pharmacol Biochem Behav 68 2001 539 543
31. C.L. Limebeer, V. Vemuri, H. Bedard, S.T. Lang, K.P. Ossenkopp, and A. Makriyannis Inverse agonism of CB1 receptors potentiates LiCl-induced nausea: Evidence from the conditioned gaping model in rats Br J Pharmacol 161 2010 336 340
32. 9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice Int J Neuropsychopharmacol 13 2010 861 876
33. B. Lutz Endocannabinoid signals in the control of emotion Curr Opin Pharmacol 9 2009 46 52
34. S.V. Mahler, K.S. Smith, and K.C. Berridge Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in the nucleus accumbens shell enhances 'liking' of a sweet reward Neuropsychopharmacology 32 2007 226 778
35. P.J. McLaughlin, K.M. Winston, C.L. Limebeer, L.A. Parker, A. Makriyannis, and J.D. Salamone The cannabinoid antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats Psychopharmacology 180 2005 286 293 (Pubitemid 40909674)
36. R. Mechoulam, and L.A. Parker The endocannabinoid system and the brain Annual Review of Psychology 64 2013 6.1 6.27
37. F.A. Moreira, D.C. Aguiar, and F.S. Guimaraes Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray Neuropharmacology 52 2007 958 965 (Pubitemid 46227483)
38. M. Navarro, E. Hernandez, R.M. Munoz, I. delArco, M.A. Villanua, and M.R. Carrera Acute administration of the CB1 cannabinoid receptor antagonist SR141716A induces anxiety-like responses in the rat Neuroreport 8 1997 491 496 (Pubitemid 27180108)
39. S. Patel, and C. Hillard Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for anxiolytic role for endogenous cannabinoid signaling J Pharmacol Exp Ther 318 2006 304 311
40. 9-tetrahydrocannabivarin in mice in vivo Br J Pharmacol 150 2007 586 594 (Pubitemid 46355554)
41. 9-tetrahydrocannabivarin Br J Pharmacol 153 2008 199 215
42. L.B. Resstel, S.R. Joca, F.A. Moreira, F.M. Correa, and F.S. Guimaraes Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats Behav Brain Res 172 2006 294 298 (Pubitemid 44148829)
43. L.B. Resstel, R.F. Tavares, S.F. Lisboa, S.R. Joca, F.M. Correa, and F.S. Guimaraes 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restrain stress in rats Br J Pharamcol 156 2009 181 188
44. G. Riedel, P. Fadda, S. McKillop-Smith, R.G. Pertwee, B. Platt, and L. Robinson Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice Br J Pharmacol 156 2009 1154 1166
45. E.M. Rock, J.M. Goodwin, C.L. Limebeer, A. Breuer, R.G. Pertwee, and R. Mechoulam Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews Psychopharmacology 215 2011 505 512
46. R.J. Rodgers, J. Haller, J. Halasz, and E. Mikics "One-trial sensitization" to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated pus-maze Eur J Neurosci 17 2003 1279 1286 (Pubitemid 36459782)
47. J.D. Salamone, P.J. McLaughlin, K. Sink, A. Makriyannis, and L.A. Parker Cannabinoid CB1 receptor inverse agonist and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions Physiol Behav 91 2007 383 388 (Pubitemid 47016540)
48. A.R. Schier, N.P. Ribeiro, A.C. de Oliverira e Silva, J.E. Hallak, J.A. Crippa, A.E. Nardi, and A.W. Zuardi Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug Rev Bras Psiquiatr 34 2012 S104 S117
49. L.P. Shearman, K.M. Rosko, R. Fleisher, J. Wang, S. Xu, and X.S. Tong Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice Behav Pharmacol 14 2003 573 582
50. K.S. Sink, P.J. McLaughlin, J.A. Wood, C. Brown, P. Fan, and V.K. Vemuri The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats Neuropsychopharmacology 33 2008 946 955 (Pubitemid 351252707)
51. K.S. Sink, K.N. Segovia, J. Sink, P.A. Randall, L.E. Collins, and M. Correa Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG7142 Eur Neuropsychopharmacol 20 2010 112 122
52. K.S. Sink, K.N. Segovia, L.E. Collins, E.J. Markus, V.K. Vemuri, and A. Makriyannis The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats Pharmacol Biochem Behav 95 2010 479 484
53. A. Straiker, and K. Mackie Depolarization-induced suppression of excitation in murine autaptic hippocampal neurons J Physiol 569 2005 501 517 (Pubitemid 41830118)
54. E. Sulcova, R. Mechoulam, and E. Fride Biphasic effects of anandamide Pharmacol Biochem Behav 59 1988 347 352
55. 9- tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist Br J Pharmacol 146 2005 917 926 (Pubitemid 41722163)
56. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol Biochem Behav 81 2005 331 342 (Pubitemid 40807131)
57. J.M. Whitkin, E.T. Tzavara, and G.G. Nomikos A role for cannabinoid CB1 receptors in model of anxiety disorders Behav Pharmacol 16 2005 315 331 (Pubitemid 41404804)
58. 1A receptors Br J Pharmacol 159 2010 122 128